iBio (IBIO) Short term Debt (2023 - 2025)

iBio's (IBIO) quarterly Short term Debt came in at $16000.0 in Q3 2025, down 91.21% year-on-year from $182000.0 in Q3 2024, and down 75.0% on a QoQ basis from $64000.0 in Q2 2025.

iBio (IBIO) Short term Debt (2023 - 2025) Analysis & Trends

iBio (IBIO) has 3 years of Short term Debt data on file, last reported at $16000.0 in Q3 2025.

  • On a quarterly basis, Short term Debt fell 91.21% year-over-year to $16000.0 in Q3 2025; TTM through Sep 2025 was $16000.0, a 91.21% decrease from a year earlier, with the FY2025 full-year figure at $64000.0, down 64.04% from the prior year.
  • Short term Debt for Q3 2025 stood at $16000.0, down from $64000.0 in the prior quarter.
  • Over the last five years, Short term Debt for IBIO reached as high as $182000.0 in Q3 2024 and fell as low as $16000.0 in Q3 2025.
  • Historically, Short term Debt has averaged $123571.4 across 3 years, with a median of $155000.0 in 2024.
  • Across the five-year window, Short term Debt increased 11.25% in 2024 and slumped 91.21% in 2025, its largest moves.
  • Year by year, Short term Debt stood at $160000.0 in 2023, then declined by 3.12% to $155000.0 in 2024, then slumped by 89.68% to $16000.0 in 2025.
  • Per Business Quant data, the three most recent Short term Debt figures were $16000.0 in Q3 2025, $64000.0 in Q2 2025, and $110000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 iBio 172.22 Mn 172.22 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 16,000.00
Jun 30, 2025 64,000.00
Mar 31, 2025 110,000.00
Dec 31, 2024 155,000.00
Sep 30, 2024 182,000.00
Jun 30, 2024 178,000.00
Jun 30, 2023 160,000.00